IDO1 and cancer: Another metabolic feature common among multiple cancer types is increased levels of kynurenine.11 As mentioned above, kynurenine is a product of IDO, a tryptophan-catabolising enzyme, and is an inhibitor of T-cell proliferation and effector function, and dendritic cell immunogenicity.